Evidence map›Paper›PMID 22122146›Full record

ReviewBehavioral neuroscience2011

Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches.

Martin Sarter, Giovanna Paolone

Abstract readReview
In one paragraph

Review in Behavioral neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Membrane Interactions and Toxicity by Misfolded Protein Oligomers.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
  13. Cholinergic Signaling Dynamics and Cognitive Control of Attention.Current topics in behavioral neurosciences · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Martin SarterDepartment of Psychology, University of Michigan, Ann Arbor, MI 48103-8862, USA. msarter@umich.edu
Giovanna Paolone
University of Michigan–Ann Arbor · US

Funding

Choline transporter capacity limits motivated behavior on mice, rats, and humansR01MH086530 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTER, MARTIN F · 2010 to 2014
$1.9M
Nicotinic regulation of cortical ACh release and behavioral functionR01MH080332 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTER, MARTIN F · 2007 to 2010
$1.2M
NIMH NIH HHS MH080332NIMH NIH HHS MH086530NIMH NIH HHS R01 MH080332NIMH NIH HHS R01 MH086530
6 · The paper itself

Abstract

The cognitive control of attention involves maintaining task rules in working memory (or "online"), monitoring reward and error rates, filtering distractors, and suppressing prepotent, and competitive responses. Weak attentional control increases distractibility and causes attentional lapses, impulsivity, and attentional fatigue. Levels of tonic cholinergic activity (changes over tens of seconds or minutes) modulate cortical circuitry as a function of the demands on cognitive control. Increased cholinergic modulation enhances the representation of cues, by augmenting cue-evoked activity in thalamic glutamatergic afferents, thereby increasing the rate of detection. Such cholinergic modulation is mediated primarily via α4β2* nicotinic acetylcholine receptors. Animal experiments and clinical trials in adult patients with ADHD indicate that attentional symptoms and disorders may benefit from drugs that stimulate this receptor. Tonic cholinergic modulation of cue-evoked glutamatergic transients in prefrontal regions is an essential component of the brain's executive circuitry. This circuitry model guides the development of treatments of deficits in attentional control.

Indexed as

AnimalsAttentionAttention Deficit Disorder with HyperactivityCholinergic FibersCognitionHumansImpulsive BehaviorNerve NetNicotinic AgonistsReceptors, NicotinicTreatment OutcomeNicotinic AgonistsReceptors, Nicotinic

Identifiers

PMID22122146
PMCPMC3235713
OpenAlexW1987586407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.